Pharmacogenomics Archives - Page 2 of 2

Neuromodulation Techniques: State Of The Science

On-Demand Webinar July 11, 2018

Clinicians managing patients with behavioral health issues are presented with various diagnostic and treatment challenges, spanning the areas of neurobiology, adherence, safety, and medication tolerability. Currently available pharmacotherapeutic, psychotherapeutic, and… Read More

Webinar Summary – Pharmacogenomics & Personalized Medicine: Where Are We Now & Where Are We Going?

Article November 3, 2017

This summary was developed utilizing the full recorded presentation of this virtual forum, which is available on PsychU for all members free of charge. For full sourcing and polling results,… Read More

Recognition & Treatment Of Mood Disorders In Primary Care: Highlighting Integrated Care Between The Pharmacist & Physician

On-Demand Webinar October 11, 2017

The primary care setting is often the default for treatment of mood disorders, but primary care physicians can become overwhelmed providing the comprehensive medical and mental health care needed by… Read More

Pharmacogenomics & Personalized Medicine: Where Are We Now & Where Are We Going?

On-Demand Webinar August 8, 2017

In this webinar, Henry A. Nasrallah, MD and Rifaat El-Mallakh, MD, review foundational concepts related to the cytochrome p-450 system with an emphasis on current genetic testing capabilities, issues related… Read More

Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

Article March 22, 2017

This summary was developed utilizing the full recorded presentation of this virtual forum, which is available on PsychU for all members free of charge. For full sourcing or polling results,… Read More

Follow Up Q&A – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

Podcast March 15, 2017

During this question and answer session, Henry A. Nasrallah, MD and Roger Sommi, PharmD, BCPP, FCCP respond to unanswered questions from their webinar entitled “Treatment Of Schizophrenia: Focus On Psychopharmacology… Read More

Webinar Summary – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

Article March 15, 2017

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members free of charge. For full sourcing and polling results, please… Read More

Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry (Inflammation Series Part 1)

On-Demand Webinar February 14, 2017

During this webinar, Dr. Roger S. McIntyre, Professor of Psychiatry and Pharmacology (University of Toronto), Head of the Mood Disorders Psychopharmacology Unit (University Health Network), and Executive Director of the… Read More

Cost Of Illness For Bipolar Disorder: A Systematic Review Of The Economic Burden

Article October 14, 2016

Key Messages This review of cost-of-illness studies evaluated the economic burden of bipolar disorder (BD) from an international perspective. Twenty-two cost-of-illness studies were identified in a literature search, 21 of… Read More

Glutamate Metabolism In Major Depressive Disorder

Article October 14, 2016

Key Messages Emerging evidence suggests that altered mitochondrial function and amino acid metabolism in the brain may be associated with depression and other mood disorders. This study used 13C magnetic… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: